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ABSTRACT
Myocardial infarction is diagnosed when blood levels of biomarkers are increased in the clinical setting of acute myocardial 
ischemia. Among the biomarkers, troponin I is the preferred biomarker indicative of myocardial necrosis. It is tissue specific 
for the heart. Myocardial infarction is rarely reported following seizure. We report a case of elevated troponin I in a patient 
after an episode of generalized tonic-clonic seizure. The diagnosis was type 2 myocardial infarction. (Korean Circ J 2011; 
41:681-684)
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Introduction
Elevation in cardiac troponin (I or T) reflects myocardial 
necrosis.
1) If there are no other etiologies of myocardial ne-
crosis, such as myocarditis, aortic dissection, pulmonary 
embolism, congestive heart failure and renal failure, cardiac 
troponin elevation is indicative of myocardial infarction due 
to acute myocardial ischemia.
1-3) Cardiac troponin (I or T) is 
nearly absolutely myocardial specific and has high clinical 
sensitivity, reflecting microscopic zones of myocardial ne-
crosis.
2) Ischemic electrocardiographic (ECG) changes fol-
lowing seizure have been documented in refractory epileptic 
patients.
4) However, clinically defined myocardial infarction 
is a rare complication of epilepsy.
5) We herein report a patient 
referred to us for elevated cardiac biomarker levels following 
an episode of generalized tonic-clonic seizure. 
Case
A 50 year-old man with history of recurrent epileptic sei-
zure was admitted to the emergency room after an episode 
of seizure in July 2010. He had collapsed suddenly due to ge-
neralized tonic-clonic seizure lasting 5 minutes. On admis-
sion, he denied symptoms such as chest pain, shortness of br-
eath, recent history of fever, or flu-like illness. He was known 
to experience recurrent epileptic seizures of traumatic origin 
after a fall, for which he was treated for intracranial and sub-
dural hemorrhage in 2007. Since then, he had been on antiepi-
leptic medication. Other past history was unremarkable and 
he had no cardiovascular risk factors.
On admission, neurologic examinations were normal and 
the patient was alert. Emergent brain magnetic resonance 
imaging (MRI) showed stabilized chronic damage secondary 
to the previous fall, in the absence of any findings suggestive 
of recent cerebral damage (Fig. 1). His vital signs were stable: 
blood pressure 110/70 mm Hg; heart rate 72 beats per min-
utes and breathing rate 18 per minutes. His chest was clear 
on auscultation. Cardiovascular examination was normal. His 
heart rhythm was regular without associated gallops or mur-
murs. His ECG showed normal sinus rhythm. Blood tests 
were within the normal limits, with the exception of creatine 
phosphokinase (231 U/L, normal <180 U/L), myoglobin (157 
ng/mL, normal <92.5 ng/mL) and cardiac troponin I (0.91 
ng/mL, normal <0.07 ng/mL). After 3 hours, cardiac tropo-682   Type 2 Myocardial Infarction Following Generalized Tonic-Clonic Seizure
nin I and MB fraction of creatinine phosphokinase were 7.29 
ng/mL (normal <0.07 ng/mL) and 8.1 ng/mL (normal <3.6 
ng/mL), respectively. Echocardiography revealed normal 
global and regional wall motion with an ejection fraction of 
68%. Computed tomography (CT) for coronary artery sh-
owed more than 50% stenosis in the middle left anterior de-
scending coronary artery (Fig. 2). So, coronary angiography 
was performed, showing about 30% stenosis of the middle 
left anterior descending coronary artery (Fig. 3) and ergono-
vine provocation test was negative. Finally, the patient was 
diagnosed clinically with type 2 myocardial infarction. The 
lesion was treated with diltiazem and nitrate until ergono-
vine test was performed. Antiepileptic medication and dilti-
azem was continued for secondary prevention. Cardiac tro-
ponin I was normalized after 5 days of diagnosis.
Discussion
Various types of myocardial infarction can be clinically clas-
sified. Among them, type 2 myocardial infarction is caused 
by ischemia due to either increased oxygen demand or de-
creased oxygen supply.
3) The possible causes of type 2 myo-
Fig. 1. Fluid attenuated inversion recovery brain magnetic resonance 
image. This showed high signal intensity around a previous hem-
orrhage site in the left frontal lobe, indicating malatic change after 
hemorrhage without evidence of newly developed lesions.
Fig. 2. Computed tomography for coronary artery showing more than 50% stenosis of the middle left anterior descending artery (white arrow).
Fig. 3. Coronary angiography showed 30% stenosis in the middle left anterior descending artery in the left lateral oblique cranial view (white 
arrow) (A) and there was no stenosis of the right coronary artery (B).
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cardial infarction after a seizure are numerous, but mainly re-
lated to an imbalance between oxygen supply and myocardial 
metabolic demand.
6) This can be caused by increased mus-
cular activity associated with seizures or by massive cate-
cholamine release from sympathetic nerve endings, causing 
increase in heart rate, arterial blood pressure and myocardial 
contractility. Elevation of troponin I may occur frequently in 
patients with supraventricular tachycardia, even in the abs-
ence of coronary artery disease.
7) Generalized tonic-clonic sei-
zure can be considered a physiological cardiac stress test. It is 
well known that acute cerebrovascular events can induce car-
diac disorders.
8) However, in our patient, we excluded acute 
cerebrovascular causes on radiological and clinical grounds.
There are several non-cardiac and cardiac conditions other 
than acute coronary syndrome that lead to increase in cardiac 
troponin I, such as myocarditis, aortic dissection, pulmonary 
embolism, congestive heart failure and renal failure.
9) In our 
patient, we could not identify evidence of other etiologies caus-
ing elevation in cardiac troponin I. 
For diagnosis of acute myocardial infarction, there should 
be at least one symptom of ischemia, ECG changes indicative 
of new ischemia and imaging evidence of new loss of viable 
myocardium or new regional wall motion abnormality, in 
addition to elevation in cardiac biomarkers (preferably tro-
ponins).
3) However, in cases concordant with a seizure epi-
sode, it will be difficult to apply these diagnostic criteria of 
myocardial infarction due to the following reasons. Chest 
pain may be absent in as many as 75% of documented episo-
des of myocardial ischemia, with 30% of myocardial infarc-
tion being either silent or associated with atypical chest 
pain.
10) In addition, an epileptic cannot complain of symp-
toms, such as chest pain or discomfort during a seizure. The 
ECG is not sufficiently diagnostic in 20% of patients with 
myocardial infarction.
11) In one multi-hospital observational 
study, only 57% of patients with acute myocardial infarction 
had diagnostic ECG and 7.9% had normal ECG, who tend-
ed to be younger and being male
12) and it is difficult to obtain 
an ECG during a seizure. The troponin levels are valuable for 
early diagnosis, and the prediction of the long term prognosis 
in ACS patients with a normal ECG.
13) Imaging techniques, 
such as echocardiography, radionuclide ventriculography, 
myocardial perfusion scintigraphy and MRI may play roles 
in patients with suspected myocardial infarction. However, 
it has been known that when an infarction thickness of myo-
cardium is 20% or more, wall motion abnormality can be de-
tected in echocardiography. Therefore, in cases with micro-
scopic (focal) or small infarction, wall motion abnormality 
may not be detected by conventional echocardiography. In 
addition, although radionuclide imaging is the only com-
monly available direct method of assessing viability, it has 
relatively low image resolution for detecting small areas of 
infarction. However, contrast enhanced cardiovascular MRI 
(CMR) systematically detects subendocardial infarcts miss-
ed by single photon emission computed tomography.
14) There-
fore, CMR would play an important role in the detection of 
suspected myocardial infarction.
In one analytic cross-sectional study, cardiac troponin I 
following seizure was within the normal limits in 49 patients 
with uncomplicated epileptic seizures and healthy cardiovas-
cular systems.
15) No elevation in cardiac troponins levels was 
seen in 11 patients after monitored seizure, indicating that 
myocardial injury does not occur during uncomplicated sei-
zure.
16) In two studies, however, the duration of seizure was 
short and this induced only moderate tachycardia. The 
mean age of monitored patients in these studies was 21 and 
34 years, respectively. This means that seizures as physiologic 
cardiac stress did not exceed myocardial functional reserve 
of epileptics. If there were elderly epileptics with lower myo-
cardial functional reserve, or when duration of a seizure was 
long enough, elevation of troponin I may be seen. 
Sudden unexplained death in epilepsy exceeds the expect-
ed rate of sudden death in the general population by nearly 
24 times.
17) Cardiac pathologic conditions indicative of myo-
cardial injury have been reported in association with sudden 
unexplained death in epileptic patients.
18) These findings lead 
to the consideration of suspected coronary artery disease in 
patients showing elevated cardiac troponins following a sei-
zure. In previously reported cases, two patients had signifi-
cant stenosis of the coronary arteries and five patients had 
no or mild stenosis of coronary artery despite elevated cardi-
ac troponins.
7)19)20) In the first two cases, only a minor increase 
in metabolic demand due to short seizure might have caused 
myocardial infarction due to lower myocardial functional 
reserve.
In the management of type 2 myocardial infarction follow-
ing seizure, antiepileptic medication is important treatment 
that reduces episodes of increased oxygen demand. Assum-
ing that type 2 myocardial infarction after a seizure is related 
to excess catecholamine release, beta blocker and non-dihy-
dropyridine calcium channel blocker may have preventive ef-
fects on secondary changes, such as increased heart rate and 
arterial blood pressure. The correction of risk factors for co-
ronary artery disease may be helpful to improve myocardial 
functional reserve.
In conclusion, in patients with no significant coronary ar-
tery disease, myocardial infarction can occur following sei-
zure activity, especially in patients with lower myocardial func-
tional reserve. This is type 2 myocardial infarction. Although 
elevation of cardiac troponins is among the three established 
criteria for the diagnosis of acute myocardial infarction after 
seizure, type 2 myocardial infarction should be considered 
and be excluded first, before calling it a false positive assay 
for cardiac troponins.684   Type 2 Myocardial Infarction Following Generalized Tonic-Clonic Seizure
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